CDR-4

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Superagonistic anti-CD28 antibodies
US 2006286104 A1申请人: TEGENERO AG优先权: 2006
US
8 件公开
FRIZZLED RECEPTOR ANTIBODIES AND USES THEREOF
EP 4013793 A1申请人: MODMAB THERAPEUTICS INC优先权: 2019
CN
EP
US
WO
5 件公开
Anti-human interleukin 23 monoclonal antibody and application thereof
US 12692303 B1申请人: QYUNS THERAPEUTICS CO LTD优先权: 2020
CN
EP
US
WO
5 件公开
ANTIBODY AND USE THEREOF
- US 2024166752 A1
  申请人: HEFEI TG IMMUNOPHARMA CO LTD优先权: 2021
  CN
  EP
  US
  WO
  4 件公开
- US 20260132221 A1
  申请人: JSR CORP优先权: 2022
  CN
  EP
  US
  WO
  4 件公开
CLAUDIN18.2 HUMANIZED ANTIBODY AND APPLICATION THEREOF
US 20250332197 A1申请人: SUNSHINE LAKE PHARMA CO LTD优先权: 2022
CN
EP
US
WO
4 件公开
Nanobody targeting IL-23A and application thereof
US 20260125461 A1申请人: BEIJING MEBIO BIOTECHNOLOGY CO LTD优先权: 2024
CN
US
WO
3 件公开
Novel antibody to a carbonic anhydrase
EP 2384766 A1申请人: HELMHOLTZ ZENTRUM MUENCHEN优先权: 2010
EP
US
3 件公开
PD-1 antibodies
US 9102728 B2申请人: TYSON KERRY LOUISE优先权: 2011
US
3 件公开
Application of anti-CD19 antibody in preparation of leukemia treatment medicine
CN 117024588 A申请人: HUADAO SHANGHAI BIOMEDICAL CO LTD优先权: 2016
CN
3 件公开
MURINE ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR FOR TREATING CANCER
EP 4458857 A1申请人: PELL BIO MED TECH CO LTD优先权: 2023
CN
EP
2 件公开